NCT05977439 RECOVERS - Realigning Emotion and COgnition Via prEcision Regulation networkS
| NCT ID | NCT05977439 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2027-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2024-02-01 with a primary completion date of 2027-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this research study, the investigators are examining how brain activity (electrical and blood flow) changes during tests of emotional processing, attention and memory in the magnetic resonance imaging (MRI) scanner and outside the MRI using functional near-infrared spectroscopy (fNIRS). Investigators are also using non-invasive brain stimulation to probe different parts of the brain and measuring brain activity (electrical and blood flow). Study 1 This study includes healthy participants and researchers hope this will help us develop improved brain-based treatments for emotional difficulties like depression. Study 2 This study includes participants with depression and researchers hope this will help us develop improved brain-based treatments for emotional difficulties like depression.
Eligibility Criteria
Study 1 Inclusion Criteria * Male or female * Age 18-65 * Endorse good health with no history of mental or physical illness or implanted metal * English as a primary language * Capacity to consent * Negative urine pregnancy test if female of childbearing potential * Willingness to adhere to the study schedule and assessments Exclusion Criteria * Any current psychiatric diagnosis or current Clinical Global Impression ratings of psychiatric illness \> 1 * Neurodevelopmental disorders, history of CNS disease, concussion, overnight hospitalization, or other neurologic sequela, tumors, seizures, meningitis, encephalitis, or abnormal CT or MRI of the brain * Any head trauma resulting in loss of consciousness * Visual impairment (except the use of glasses) * Inability to complete cognitive testing * Active participation or plan for enrollment in clinical trial affecting the psychosocial function * Repeated abuse or dependence upon drugs (excluding nicotine and caffeine) or taking medications including stimulants, modafinil, thyroid medication, or steroids * Implanted devices/ferrous metal of any kind * History of seizure or epilepsy, currently taking medications that lower seizure thresholds * Claustrophobia or other conditions that would prevent the MRI assessment. * Pregnancy (or suspected/possible pregnancy or plan to become pregnant in the short term). o Urine Pregnancy Test: If the subject is a woman of childbearing potential and /or a man capable of fathering a child before, during, and/or after participation precautions should be taken. Examples of acceptable methods of birth control for participants involved in the study include birth control pills, patches, IUDs, condoms, sponges, diaphragm with spermicide, or avoiding sexual activity that could cause the subject to become pregnant. * Inability to adhere to the treatment schedule Study 2 Inclusion Criteria * Male or female * Age 18-65 * Endorse current depression, identified via the Hamilton Depression Rating Scale (HAM-D scores ≥ 17), but no history of psychosis or mania, determined via the Quick Structured Clinical Interview for DSM-5 Disorders (SCID). * English as a primary language * Capacity to consent * Negative urine pregnancy test if female of childbearing potential * Willingness to adhere to the study schedule and assessments Exclusion Criteria * Neurodevelopmental disorders, history of CNS disease, concussion, overnight hospitalization, or other neurologic sequela, tumors, seizures, meningitis, encephalitis, or abnormal CT or MRI of the brain * Any head trauma resulting in loss of consciousness * Visual impairment (except the use of glasses) * Inability to complete cognitive testing * Active participation or plan for enrollment in clinical trial affecting the psychosocial function * Repeated abuse or dependence upon drugs (excluding nicotine and caffeine) or taking medications including stimulants, modafinil, thyroid medication, or steroids * Implanted devices/ferrous metal of any kind * History of seizure or epilepsy, currently taking medications that lower seizure thresholds
Contact & Investigator
Lisa McTeague, PhD
PRINCIPAL INVESTIGATOR
Medical University of South Carolina
Frequently Asked Questions
Who can join the NCT05977439 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05977439 currently recruiting?
Yes, NCT05977439 is actively recruiting participants. Contact the research team at MCTEAGUE@MUSC.EDU for enrollment information.
Where is the NCT05977439 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT05977439 clinical trial?
NCT05977439 is sponsored by Medical University of South Carolina. The principal investigator is Lisa McTeague, PhD at Medical University of South Carolina. The trial plans to enroll 30 participants.